ontario regulation 452/16

made under the

Pharmacy Act, 1991

Made: August 25, 2016
Approved: September 14, 2016
Filed: December 15, 2016
Published on e-Laws: December 15, 2016
Printed in The Ontario Gazette: December 31, 2016

Amending O. Reg. 202/94

(GENERAL)

1. (1) Subsection 34 (1) of Ontario Regulation 202/94 is revoked and the following substituted:

(1) For the purposes of paragraph 2 of subsection 4 (1) of the Act, a member referred to in subsection (2) who meets all the requirements in subsection (3) is authorized to perform the following acts:

1. Administering a substance specified in Schedule 1 by injection to a patient.

2. Administering a substance specified in Schedule 2 by inhalation to a patient.

(2) Subsection 34 (2) of the Regulation is amended by striking out “subsection (1)” and substituting “subsections (1), (4) and (5)”.

(3) Subsection 34 (4) of the Regulation is amended by striking out the portion before clause (a) and substituting the following:

(4) For the purposes of paragraph 2 of subsection 4 (1) of the Act, a member referred to in subsection (2) is authorized to administer influenza vaccine by injection to a patient who is five years of age or older, if the member,

. . . . .

(4) Section 34 of the Regulation is amended by adding the following subsection:

(5) For the purposes of paragraph 2 of subsection 4 (1) of the Act, a member referred to in subsection (2) is authorized to administer a vaccine from one of the vaccines specified in Schedule 3 by injection to a patient who is five years of age or older, if the member,

(a) receives an informed consent from the patient or his or her authorized agent;

(b) meets all the requirements in paragraphs 2 to 6 of subsection (3); and

(c) notifies the patient’s primary care provider (if any) within a reasonable time that the member administered a vaccine to the patient and provides details respecting the administration.

2. Tables 1 and 2 of the Regulation are revoked.

3. The Regulation is amended by adding the following Schedules:

Schedule 1
Injected Substances

(Arranged by American Hospital Formulary Service (AHFS) Pharmacologic-Therapeutic Classification)

1. 8:00 Anti-infective Agents

i. 8:18 Antivirals

A. 8:18.08.04 HIV Entry and Fusion Inhibitors

1. Enfuvirtide

B. 8:18.20 Interferons

1. Interferon Alfa-2b

2. Peginterferon alfa-2a

3. Peginterferon alfa-2b

2. 10:00 Antineoplastic Agents

1. Goserelin

2. Leuprolide

3. Methotrexate

3. 12:00 Autonomic Drugs

i. 12:12 Sympathomimetic (Adrenergic) Agents

A. 12:12.12 Alpha- and Beta-Adrenergic Agonists

1. Scopolamine

2. Hyoscine

3. Glycopyrrolate

4. Epinephrine

4. 20:00 Blood Formation and Coagulation

i. 20:04 Antianemia Drugs

A. 20:04.04 Iron Preparations

1. Iron

ii. 20:12 Coagulants and Anticoagulants

A. 20:12.04 Anticoagulants

1. Dalteparin

2. Danaparoid

3. Enoxaparin

4. Fondaparinux

5. Heparin

6. Nadroparin

7. Tinazaparin

iii. 20:16 Hematopoietic Agents

1. Ancestim

2. Darbepoetin alfa

3. Epoetin alfa

4. Filgrastim

5. Pegfilgrastim

6. Romiplostim

5. 28:00 Central Nervous System Agents

i. 28:08 Analgesics and Antipyretics

A. 28:08.08 Opiate Agonists

1. Codeine

2. Hydromorphone

3. Meperidine

4. Morphine

B. 28:08.12 Opiate Partial Agonists

1. Nalbuphine

2. Pentazocine

ii. 28:16 Psychotherapeutic Agents

A. 28:16.08 Antipsychotics

1. Haloperidol

2. Methotrimeprazine

iii. 28:32 Antimigraine Agents

A. 28:32.28 Selective Serotonin Agonists

1. Sumatriptan

6. 40:00 Electrolytic, Caloric, and Water Balance

i. 40:12 Replacement Preparations

1. Normal saline

7. 48:00 Respiratory Tract Agents

i. 48:92 Respiratory Tract Agents, Miscellaneous

1. Omalizumab

8. 56:00 Gastrointestinal Drugs

i. 56:22 Antiemetics

A. 56:22.08 Antihistamines

1. Dimenhydrinate

2. Prochlorperazine

ii. 56:32 Prokinetic Agents

1. Metoclopropamide

iii. 56:92 GI Drugs, Miscellaneous

1. Certolizumab Pegol

2. Methylnaltrexone

9. 64:00 Heavy Metal Antagonists

1. Deferoxamine

10. 68:00 Hormones and Synthetic Substitutes

i. 68:18 Gonadotropins

1. Follitropin-alpha

2. Follitropin-beta

3. Gonadotropin-chorionic

4. Gonadotropin-chorionic-alfa

5. Gonadotropin-human

6. Lutropin-alfa

7. Menotropins

8. Urofollitropin

ii. 68:20 Antidiabetic Agents

1. Exenatide

2. Insulins

3. Liraglutide

iii. 68:22 Antihypoglycemic Agents

A. 68:22:12 Glycogenolytic Agents

1. Glucagon

iv. 68:24 Parathyroid

1. Calcitonin Salmon

2. Teriparatide

v. 68:28 Pituitary

1. Desmopressin

2. Vasopressin

vi. 68:30 Somatotropin Agonists and Antagonists

A. 68:30.04 Somatotropin Agonists

1. Somatropin

B. 68:30.08 Somatotropin Antagonists

1. Pegvisomant

vii. 68:32 Progestins

1. Medroxyprogesterone

11. 88:00 Vitamins

i. 88:08 Vitamin B Complex

1. Cyanocobalamin

2. Folic Acid

3. Methylcobalamin

4. Pyridoxine

5. Thiamine

ii. 88:12 Vitamin C

1. Ascorbic Acid

iii. 88:24 Vitamin K Activity

1. Vitamin K

12. 92:00 Miscellaneous Therapeutic Agents

i. 92:12 Antidotes

1. Leucovorin

ii. 92:20 Biologic Response Modifiers

1. Denosumab

2. Glatiramer

3. Interferon-Beta-1A

4. Interferon-Beta-1B

5. Natalizumab

iii. 92:36 Disease-modifying Antirheumatic Drugs

1. Abatacept

2. Adalimumab

3. Anakinra

4. Etanercept

5. Gold Sodium Thiomalate

6. Golimumab

7. Ustekinumab

iv. 92:40 Gonadotropin- releasing Hormone Antagonists

1. Cetrorelix

2. Ganirelix

v. 92:92 Other Miscellaneous Therapeutic Agents

1. Octreotide

13. Miscellaneous

1. Sterile Water for Injection (Diluent)

Schedule 2
Inhaled Substances

(Arranged by American Hospital Formulary Service (AHFS) Pharmacologic-Therapeutic Classification)

1. 8:00 Anti-infective Agents

i. 8:18 Antivirals

A. 8:18.28 Neuraminidase Inhibitors

1. Zanamivir

ii. 8:12 Antibacterials

A. 8:12.07.16 Monobactams

1. Tobramycin

2. Aztreonam

2. 12:00 Autonomic Drugs

i. 12:08 Anticholinergic Agents

A. 12:12.08 Antimuscarinics/Antispasmodics

1. Ipratropium

2. Tiotropium

ii. 12:12 Sympathomimetic (Adrenergic) Agents

A. 12:12.08.12 Selective Beta2- Adrenergic Agonists

1. Fenoterol

2. Formoterol

3. Salbutamol

4. Salmeterol

5. Terbutaline

iii. 12:16 Sympatholytic (Adrenergic Blocking) Agents

A. 12:16.04.04 Non-Selective alpha-Adrenergic Blocking Agents

1. Dihyroergotamine

iv. 12:92 Autonomic Drugs, Miscellaneous

1. Nicotine

3. 28:00 Central Nervous System Agents

i. 28:08 Analgesics and Antipyretics

A. 28:08.12 Opiate Partial Agonists

1. Butorphanol

ii. 28:32 Antimigraine Agents

A. 28:32.28 Selective Serotonin Agonists

1. Sumatriptan

2. Zolmitriptan

4. 40:00 Electrolytic, Caloric, and Water Balance

i. 40:12 Replacement Preparations

1. Sodium chloride

5. 48:00 Respiratory Tract Agents

i. 48:24 Mucolytic Agents

1. Dornase alfa

6. 52:00 Eye, Ear, Nose and Throat (EENT) Preparations

i. 52:02 Antiallergic Agents

1. Sodium Cromoglycate

2. Levocabastine

ii. 52:08 Anti-inflammatory Agents

A. 52:08.08 Corticosteroids

1. Beclomethasone

2. Budesonide

3. Ciclesonide

4. Flunisolide

5. Fluticasone

6. Mometasone

7. Triamcinolone

iii. 52:32 Vasoconstrictors

1. Oxymetazoline

2. Phenylephrine

3. Xylometazoline

7. 68:00 Hormones and Synthetic Substitutes

i. 68:18 Gonadotropins

1. Buserelin

2. Nafarelin

ii. 68:24 Parathyroid

1. Calcitonin Salmon

iii. 68:28 Pituitary

1. Desmopressin

2. Vasopressin

8. 92:00 Miscellaneous Therapeutic Agents

i. 92:12 Antidotes

1. Acetylcysteine

Schedule 3
Vaccines

1. Bacille Calmette-Guerin (BCG) Vaccines

2. Haemophilus Influenzae type b (Hib) Vaccines

3. Meningococcal Vaccines

4. Pneumococcal Vaccines

5. Typhoid Vaccines

6. Combined Typhoid and Hepatitis A Vaccines

7. Hepatitis A Vaccines

8. Hepatitis B Vaccines

9. Hepatitis A and B combined Vaccines

10. Herpes Zoster Vaccines

11. Human Papillomavirus (HPV) Vaccines

12. Japanese Encephalitis Vaccines

13. Rabies Vaccines

14. Varicella Vaccines

15. Yellow Fever Vaccines

Commencement

4. This Regulation comes into force on the day it is filed.

Made by:

Council of the Ontario College of Pharmacists:

Esmail Merani

President

Marshall Moleschi

Registrar

Date made: August 25, 2016